Gil I. Wolfe MD, FAAN

Gil Wolfe

Gil I. Wolfe
MD, FAAN

Professor and Chairman; Irvin and Rosemary Smith Chair of Neurology; State University of New York Distinguished Professor; Chief of Service for Neurology

Department of Neurology

Jacobs School of Medicine & Biomedical Sciences


Specialty/Research Focus

Muscle disease; Muscular Dystrophy; Neurobiology; Neurology; Neuromuscular Disorders; Neuropathology; Peripheral neuropathy

Contact Information
Dept. of Neurology
Jacobs School of Medicine and Biomedical Sciences
1010 Main St., 2nd floor
Buffalo, New York 14202
Phone: (716) 829-5063
Fax: (716) 829-4411
gilwolfe@buffalo.edu


Patient Care

This faculty member is affiliated with UBMD, practicing physicians who are also professors in the Jacobs School.

View this physician on UBMD


Professional Summary:

I arrived in January 2012 to assume the role of Chair of the Department of Neurology at Univ. at Buffalo School of Medicine and Biomedical Sciences, the State University of New York. Prior to that time, I served as Professor of Neurology at University of Texas Southwestern Medical School in Dallas, Texas. In September 2004, I was named to the Dr. Bob and Jean Smith Foundation Distinguished Chair in Neuromuscular Disease Research. I also served as Co-Director of the Muscular Dystrophy Association Clinics and Director of the Myasthenia Gravis and Peripheral Neuropathy Clinics at UT Southwestern and was the Clinical Vice Chair for the department in Dallas.

My interests in neuromuscular medicine are wide but have mainly focused on myasthenia gravis and other disorders of neuromuscular transmission, as well as peripheral neuropathies. I am board certified both in neurology and neuromuscular medicine. I am also board certified in neurophysiology, and I perform electromyography and nerve conduction studies and monitor intraoperative evoked potentials for spine surgeries and other operative cases.

My main research interests include idiopathic and immune-mediated peripheral neuropathies and myasthenia gravis. My research has been sponsored by the National Institute of Health/NINDS, Muscular Dystrophy Association, Myasthenia Gravis Foundation of America, and Food and Drug Administration. I remain actively involved in the training of younger physicians, and have directed neuromuscular medicine and clinical neurophysiology fellowships and neurology residency training programs in the past.

Education and Training:

  • MD, Medicine, University of Texas Southwestern Medical School (1989)
  • BA, Biology, Princeton University, Cum Laude (1985)

Employment:

  • Distinguished Professor, Neurology, University at Buffalo (2017-present)
  • Chief of Service, Neurology, Kaleida Health (2012-present)
  • Professor and Chairman, Neurology, Univ at Buffalo JSMBS (2012-present)
  • SUNY Distinguished Professor, Neurology (2022-present)
  • Professor, Neurology, University at Buffalo, State University of New York Jacobs School of Medicine & Biomedical Sciences (2012-present)
  • Professor, Neurology, University of Texas Southwestern Medical School (1994–2011)
  • Fellow, Neurology, University of Pennsylvania Medical Center Univ. of Pennsylvania (1993–1994)
  • Resident, Neurology, University of Pennsylvania Medical Center Univ. of Pennsylvania (1990–1993)
  • Intern, Internal Medicine, University of Pennsylvania Medical Center Univ. of Pennsylvania (1989–1990)

Awards and Honors:

  • Dr. Morris B. Bender Annual Lectureship (2024)
  • 10th Annual Mathilda Karel Spak Lecture (2022)
  • SUNY Distinguished Professor (2022)
  • Regional Top Doctor (2021)
  • Clinical Research Acheivement Award Finalist (2020)
  • Certificate of Recognition for Distinguished Service (2020)
  • Reiner Lecture (2020)
  • Carrell Krusen Neuromuscular Symposium Keynote Speaker (2020)
  • Chancellor's Award for Excellence in Scholarship and Creative Activities (2018)
  • Excellence in Teaching Pharmacy Students Award (2018)
  • Univ. at Buffalo Distinguished Professor (2017)
  • Warren Wisner Lecture in Myasthenia Gravis (2016)
  • Doctor of the Year, Myasthenia Gravis Foundation of America (2015)
  • Teacher of the Year Award (2014)
  • Buffalo Spree Magazine Top Doctor (2014)
  • Keynote Speaker (2013)
  • Distinguished Lecturer (2013)
  • Inaugural Keynote Address (2013)
  • Guest Professor Univ. of Toronto (2013)
  • Buffalo Spree Magazine Top Doctor (2013)
  • Patricia A. Smith Distinguished Chair in Neuromuscular Disease Research (2012)
  • US News and World Report (2012)
  • Inaugural Mathilda Karel-Spak Lecturer (2011)
  • Best Doctors in America (2011)
  • Best Doctors in Dallas (2011)
  • Texas Super Doctor (2011)
  • Baldwin Myasthenia Gravis Lecturer (2008)
  • American Academy of Neurology (2005)
  • Marquis' Who's Who (2005)
  • American Neurological Society (2004)
  • Trephined Cranium Resident Teaching Award (2002)
  • Lippincott Scholar (1987)

Research Expertise:

  • Electromyography (EMG): Conduct electrophysiologic tests that assess the peripheral nervous system, including the neuromuscular junction and muscle.
  • Intraoperative monitoring (IOM): Monitoring electrophysiologic properties in individual patients during surgery. It is most commonly applied for spinal surgeries, but is also used for resection of tumors affecting the brainstem and brain, itself; and can be applied in a variety of other ways as well.
  • Neuromuscular clinical trials
  • Neuromuscular disease
  • Neuromuscular disorders: Evaluate and treat the diseases of the nervous system that impact motor neurons, peripheral nerve, the neuromuscular junction, and muscle. These include peripheral neuropathies, motor neuron disease, myasthenia gravis, and inflammatory and hereditary muscle disease.
  • Neuromuscular outcome measures

Grants and Sponsored Research:

  • January 2021–March 2024
    Phase 3 randomized, double blind, placebo-controlled multicenter study to evaluate satralizumab in generalized myasthenia gravis (LUMINESCE).
    Roche
    Role: Co-Investigator
  • July 2018–June 2023
    Network of Excellence in Neuroscience Clinical Trial: NeuroNEXT
    NIH/NINDS
    Role: Principal Investigator
    $250,000
  • January 2020–June 2021
    International Treatment Guideline in Myasthenia Gravis
    MG Foundation of America
    Role: Co-Principal Investigator
  • January 2018–December 2019
    PROMISE-MG: Prospective multicenter observational cohort study of comparative
    PCORI
    Role: Co-Investigator
    $7,200
  • March 2014–August 2015
    International Myasthenia Gravis Treatment Guideline
    MG Foundation of America
    Role: Co-Principal Investigator
    $25,000
  • September 2005–July 2015
    Thymectomy Trial in Non-thymomatous MG patients on prednisone
    NIH/NINDS
    Role: Principal Investigator
    $995,672
  • August 2012–July 2013
    The Effectiveness of Prednisone for the Treatment of Ocular Myasthenia (EPITOME)FDA
    FDA
    Role: Co-Investigator
    $13,000
  • January 2010–December 2012
    Genome-wide association study in myasthenia gravis
    MG Foundation of America
    Role: Co-Investigator
    $50,000
  • April 2014
    Safety and efficacy of eculizimab in subjects with refractory myasthenia gravis
    Alexion Pharmaceuticals
    Role: Co-Investigator
    $50,000

Journal Articles:

See all (106 more)

Professional Memberships:

  • NeuroNEXT NIH/NINDS Network; Co-Chair of Recruitment, Retention and Diversity Committee (2020–2022)
  • New York State Neurological Society; President (2019–2021)
  • Association of University Professors of Neurology; Councilor, Executive Committee (2014–present)
  • Western ALS Study Group; Investigator (2013–present)
  • GBS/CIDP Foundation International; Medical Advisory Board Member Center of Excellence (2012–present)
  • American Neurological Association; Member (2004–present)
  • Myasthenia Gravis Foundation of America; Member of MSAB (2001–present)
  • Muscle Study Group; Site Investigator (2000–present)
  • AANEM; member and committee chair (1993–present)
  • American Academy of Neurology; Fellow (1991–present)

Presentations:

  • "Core Concepts in Neuropathic Pain Management: Safe and Appropriate Opioid Prescribing in Neurology" Annual Meeting Education Program, American Academy of Neurology (2023)
  • "Myasthenia Gravis in 2022: A Year in Review" Rare Disease Connect in Neurology Annual Meeting (2022)
  • "Myasthenia Gravis Pathogenesis: What is the Role of the Thymus" Rare Disease Connect in Neurology Annual Meeting (2022)
  • "The Role of Neonatal Fc Receptor Blocking Therapeutics in the Management of Patients with Generalized Myasthenia Gravis" 6th Annual Meeting of the Illinois State Neurological Society (2022)
  • "Evolving Autoantibodies and Treatment Landscape in Myasthenia Gravis: The 2020 Update of the Consensus Treatment Recommendations for MG" 17th International Congress on Neuromuscular Diseases (2022)
  • "Myasthenia Gravis: The Evolving Therapeutic Landscape" International Academic Seminar on Progress in Myasthenia Gravis, Hebei Medical University (2022)
  • "Myasthenia Gravis: The Evolving Therapeutic Landscape" 10th Annual Mathilda Karel Spak Lecture, Univ. of California Irvine Health Neuromuscular Colloquium (2022)
  • "Core Concepts in Neuropathic Pain Management: Safe and Appropriate Opioid Prescribing in Neurology" Annual Meeting Education Program, American Academy of Neurology (2022)
  • "Treatment Decisions for Disorders with Multiple Therapies: Myasthenia Gravis" Muscular Dystrophy Association Clinical and Scientific Conference (2022)
  • "New Treatments in Myasthenia Gravis: When and Should I?" National Patient Conference, Myasthenia Gravis Foundation of America (2022)
  • "Evolving Therapeutic Landscapes in the Management of Myasthenia Gravis" Philippine Neurological Association 43rd Annual Convention (2021)
  • "Research and Clinical Trials Update in Myasthenia Gravis" Northeast Regional Conference, Myasthenia Gravis Foundation of America (2021)
  • "Autoantibodies and the Evolving MG Treatment Landscape: The 2020 Update of the Consensus International Treatment Recommendations for MG" AANEM Annual Meeting (2021)
  • "New Developments in Managing Myasthenia Gravis" 3rd Annual International Congress on the Future of Neurology (2021)
  • "The 2020 Update of the Consensus International Treatment Recommendations for Myasthenia Gravis" Keynote address: 1st Chinese Summit on Innovative Medicine and Public Welfare in Myasthenia Gravis and Neurology (2021)
  • "Therapeutic Landscape and Novel Therapies for Myasthenia Gravis" Advanced Practice Provider education series, American Association of Neuromuscular and Electrodiagnostic Medicine (2021)
  • "Core Concepts in Pain Management" American Academy of Neurology Virtual Annual Meeting (2021)
  • "Therapeutic Landscape and Novel Therapies for Myasthenia Gravis" Dept. of Neurology Grand Rounds, St. Louis University School of Medicine (2021)
  • "Minimal Manifestation Status and Prednisone Withdrawal in the MGTX Trial" Clinical and Translational Science Institute Annual Forum, Univ. at Buffalo (2021)
  • "Therapeutic Landscape and Novel Therapies for Myasthenia Gravis" Dept. of Neurology Grand Rounds, Penn State College of Medicine (2021)
  • "MGTX: A Closer Look into Outcomes from the Thymectomy Trial in Myasthenia Gravis" Dept. of Medicine Grand Rounds, Oakland University William Beaumont School of Medicine (2021)
  • "Therapeutic Landscape and Novel Therapies for Myasthenia Gravis" Neuroscience Lecture Series, MIND Clinic (2021)
  • "Reiner Lecture: Therapeutic Landscape and Novel Therapies for Myasthenia Gravis" American Association of Neuromuscular and Electrodiagnostic Medicine Annual Scientific Meeting (2020)
  • "Myasthenia Gravis: Updates in Research" Muscular Dystrophy Association Engage Myasthenia Gravis Virtual Symposium (2020)
  • "Neuromuscular Junction Disorders: Thymectomy" 16th International Congress on Neuromuscular Diseases, Virtual Plenary Session, (2020)
  • "COVID-19 and Neuromuscular Medicine" Mini Grand Rounds COVID-19 Series (2020)
  • "Chronic Inflammatory Demyelinating Polyneuropathy: assessing the application of intravenous and subcutaneous immunoglobulin, featuring a patient perspective" Pharmacy Times continuing education program (2020)
  • "Carrell-Krusen Keynote Lecture: Novel Therapies for Myasthenia Gravis" 42nd Annual Carrell Krusen Neuromuscular Symposium; Univ. of Texas Southwestern Medical Center (2020)
  • "MGTX: A Closer Look into Outcomes from the Thymectomy Trial in Myasthenia Gravis" Grand Rounds; Univ. of Texas Southwestern Medical Center; Dept of Neurology and Neurotherapeutics (2020)
  • "A Closer Look into Outcomes from the Thymectomy Trial in Myasthenia Gravis" Grand Rounds; Univ. of Maryland School of Medicine; Dept. of Neurology (2020)
  • "MGTX: A Closer Look into Outcomes from the Thymectomy Trial in Myasthenia Gravis" Grand Rounds; Univ. of Washington Medical Center; Dept. of Neurology (2020)
  • "Evolution of Pathogenic Players and Treatment in Myasthenia Gravis" 25th Neurology Time Conference; Peking Union Medical College (2019)
  • "Neurology Update 1: Neuromuscular Disease" AAN Annual Meeting; American Academy of Neurology (2019)
  • "Primer on Myasthenia Gravis" 25th Neurology Time Conference; Peking Union Medical College (2019)
  • "Respiratory and Crisis Management in Myasthenia Gravis" 5th Neurorespiratory Conference; Weizmann Institute (2019)
  • "Therapeutic Landscape and Novel Therapies for Myasthenia Gravis" Mini-symposium on Myasthenia Gravis; Tel Aviv University; Sackler Faculty of Medicine (2019)
  • "Practical Implementation of New Therapies: Treatment Landscape in Myasthenia Gravis" 2019 MDA Clinical and Scientific Conference; Muscular Dystrophy Association (2019)
  • "Intraoperative Neurophysiologic Monitoring" Grand Rounds; Stony Brook University Renaissance School of Medicine; Dept of Neurology (2019)
  • "MGTX: A Closer Look at Data from the Randomized Trial of Thymectomy in Myasthenia Gravis" Neurosciences Update 2018; Univ. of Kansas Health System; Dept. of Neurology (2018)
  • "Immunotherapeutic Developments in Myasthenia Gravis" Immunoglobulin National Society National Conference; IgNS (2018)
  • "Neuropathic Pain Management in Clinical Practice" Medical Center Conference; Galilee Medical Center (2018)
  • "MGTX: A Deeper Dive into Outcomes from the Thymectomy Trial in Non-thymomatous Myasthenia Gravis" Grand Rounds; Univ. of Pittsburgh School of Medicine; Dept of Neurology (2018)
  • "Clinical Implications of Old and New Pathogenic Players in Myasthenia Gravis" NerveCon III (2018)
  • "Neuropathic Pain Management in Clinical Practice" NerveConIII (2018)
  • "Evolution of Monoclonal Ab Treatment Approaches in MG" 15th Intl Congress on Neuromuscular Diseases; ICNMD (2018)
  • "Overview of Treatment Guidelines for Myasthenia Gravis" 15th Intl Congress on Neuromuscular Diseases; ICNMD (2018)
  • "Randomized Controlled Trial of Thymectomy: A Deeper Dive" 15th Intl Congress on Neuromuscular Diseases; ICNMD (2018)
  • "Myasthenia Gravis Today: Treatment Update and Future Directions" Immunotherapy for Neurologic Disorders 2018; University of Pennsylvania Health System & Penn; Dept. of Neurology (2018)
  • "Treatment of Myasthenia Gravis: Update and Future Directions" Grand Rounds; Univ. of Virginia School of Medicine; Dept of Neurology (2017)
  • "Management of Myasthenic Crisis" 54th Congreso Argentino de Neurologia; Congreso Argentino de Neurologia (2017)
  • "Update in the Treatment of Myasthenia Gravis" 54th Congreso Argentino de Neurologia; Congreso Argentino de Neurologia (2017)
  • "Treatment Approach in Painful Peripheral Neuropathy" 3rd Annual UT Southwestern Neurotherapeutics Update; Univ. of Texas Southwestern Medical Center; Dept. of Neurology and Neurotherapeutics (2017)
  • "An International Consensus Guidance Statement for the Management of Myasthenia Gravis" 4th Ottawa International Conference on Neuromuscular Disease and Biology; Univ. of Ottawa (2017)
  • "Myasthenia Gravis: Advances in Therapy" 4th Ottawa International Conference on Neuromuscular Disease and Biology; University of Ottawa (2017)
  • "New Neuromuscular Therapies: Snapshot of Immunotherapeutic Developments" American Association of Neuromuscular and Electrodiagnostic Medicine Annual Meeting; AANEM (2017)
  • "Comparing and Contrasting Treatment Strategies around the World" 13th International Conference on Myasthenia Gravis and Related Disorders; NYAS/MGFA; New York Academy of Sciences (2017)
  • "MGTX: Primary and Secondary Outcome Measures" 13th Intl Conference on Myasthenia Gravis and Related Disorders; NYAS/MGFA (2017)
  • "MGTX: Results of the Multinational Thymectomy Trial in Non-thymomatous Myasthenia Gravis" 2017 American Academy of Neurology Annual Meeting; American Academy of Neurology; Clinical Trials Plenary Session (2017)
  • "Results from the Thymectomy Trial" MGFA National Conference; ; MG Foundation of America (2017)
  • "Thymectomy in Non-Thymomatous Myasthenia Gravis: Results from MGTX, a Randomized, Controlled Trial" Grand Rounds; Univ. of California Irvine School of Medicine; Dept. of Neurology (2017)
  • "The World Speaks: An International Treatment Recommendation for Myasthenia Gravis" Special Lecture; Meir Medical Center; Dept of Neurology (2017)
  • "Thymectomy in Non-Thymomatous Myasthenia Gravis: Results from MGTX, a Randomized, Controlled Trial" Grand Rounds; Stanford University; Dept of Neurology and Neuroscience Grand Rounds (2017)
  • "MGTX: Results from the Thymectomy Trial in Non-thymomatous Myasthenia Gravis" Grand Rounds; New York-Presbyterian/Weill Cornell Medical Center; Dept. of Neurology (2016)
  • "Myasthenia Gravis: Antibody Revolution to Treatment Evolution" New York State Neurological Society Fall Conference; NYS Neurological Society (2016)
  • "MGTX: Results from the Thymectomy Trial in Non-thymomatous Myasthenia Gravis" MSG Annual Meeting; Muscle Study Group; MSG (2016)
  • "MGTX: Results of the Multinational Thymectomy Trial in Non-thymomatous Myasthenia Gravis" Annual Warren Wismer Lecture in Myasthenia Gravis; University of Alberta Faculty of Medicine and Dentistry; Grand Rounds, Dept of Neurology (2016)
  • "An International Treatment Recommendation for Myasthenia Gravis" VIII Simposio Internacional de Neurologia; Universidad de los Andes (2016)
  • "Pharmacological Treatment Update in Neuropathic Pain" VIII Simposio Internacional de Neurologia; Univeridad de los Andes (2016)
  • "Results of the Thymectomy Trial in Myasthenia Gravis" International Congress of Neuromuscular Diseases; World Federation of Neurology (2016)
  • "Treatment of Myasthenia Gravis: General Treatment Approaches" International Congress of Neuromuscular Diseases; World Federation of Neurology (2016)
  • "The World Speaks: International Consensus Recommendations for Myasthenia Gravis Management" Grand Rounds; SUNY Downstate Medical Center; Dept of Neurology (2016)
  • "Myasthenia Gravis: UnMuSKing a New Phenotype" Grand Rounds; Albany Medical College; Neuroscience Institute (2015)
  • "Myasthenia Gravis: UnMuSKing a Phenotype" Grand Rounds; NYU Langone Medical Center; Dept of Neurology (2015)
  • "The World Speaks: International Consensus Recommendations for Myasthenia Gravis Management" American Association of Neuromuscular and Electrodiagnostic Medicine Annual Meeting; AANEM (2015)
  • "Management Dilemmas in Neuroimmunological Conditions: Thymectomy in MG" 2nd World Congress of Neurotherapeutics (2015)
  • "Myasthenia Gravis: UnMuSKing a New Phenotype" Grand Rounds, Mt. Sinai Beth Israel Mirken Dept. of Neurology; Mt. Sinai Beth Israel Medical Campus; Dept. of Neurology (2015)
  • "What's New in Treatment Strategies for Myasthenia Gravis?" Canadian Neurological Sciences Federation 50th Congress; Canadian Neurological Sciences Federation (2015)
  • "What’s New in Treatment Strategies for Myasthenia Gravis?" Canadian Neurological Sciences Federation 50th Congress (2015)
  • "What‘s New in Treatment Strategies for MG in the New Era" 56th Annual Meeting, Japanese Society of Neurology; Japanese Society of Neurology (2015)
  • "Treatment of Neuropathic Pain" Neurology Update for the Primary Care Professional; Univ. at Buffalo SMBS/SUNY; Dept. fof Neurology (2015)
  • "Myasthenia Gravis: UnMuSKing a New Phenotype" Grand Rounds, Univ. of Pennsylvania Perelman School of Medicine; Univ. at Pennsylvania Perelman School of Medicine; Dept. of Neurology (2015)
  • "Myasthenia Gravis: UnMuSKing a New Phenotype" Grand Rounds, Indiana University School of Medicine; Indiana University School of Medicine; Dept. of Neurology (2014)
  • "Myasthenia Gravis: UnMuSKing a New Phenotype" Neuromuscular Grand Rounds, Case Western Reserve School of Medicine; Case Western Reserve University School of Medicine; Neuromuscular Division (2014)
  • "What‘s New in Managing Myasthenia Gravis" Grand Rounds, Case Western Reserve University School of Medicine; Case Western Reserve University School of Medicine; Dept. of Neurology (2014)
  • "What‘s New in Managing Myasthenia Gravis" Annual Fall Symposium, NY State Neurological Society; NY State Neurological Society (2014)
  • "Myasthenia Gravis: UnMuSKing a New Phenotype" Grand Rounds, LSU Health Sciences Center; LSU Health Sciences Center-Shreveport School of Medicine; Dept of Neurology (2014)
  • "Treatment of Painful Peripheral Neuropathy" American Academy of Neurology Annual Meeting; AAN (2014)
  • "What's New in Managing Adult Myasthenia Gravis" Muscular Dystrophy Association Clinical Conference; MDA (2014)
  • "Research Update on Myasthenia Gravis and Status of the MGTX Trial" Dept of Neurology Conference, Tel Aviv Univ. Sackler School of Medicine; Ichilov Hospital, Tel Aviv Univ Sackler School of Medicine; Dept of Neurology (2013)
  • "MGTX-the NIH-Funded Thymectomy Trial in Non-thymomatous MG" Second Annual Wright State University and Premier Health Neuroscience Institute Symposium; Wright State Univ. Boonshoft School of Medicine (2013)
  • "Research Update in Myasthenia Gravis" Fourth Annual MG Patient Education Conference, Houston Methodist Neurological Institute; Houston Methodist Neurological Institute (2013)
  • "Overcoming Hurdles of Developing and Performing Clinical Trials" Muscle Study Group Annual Meeting; Muscle Study Group (2013)
  • "Myasthenia Gravis Research Update" First Annual MDA Muscle Summit, Penn State Hershey Medical Center; Penn State Hershey Medical Center (2013)
  • "Myasthenia Gravis Research Update" MG Foundation of America National Conference; MGFA (2013)
  • "Status of the MGTX Trial in Nonthymomatous MG Patients" International Workshop on the Thymus, Univ. of Padua; Univ. of Padua (2013)
  • "Myasthenia Gravis: UnMuSKing a New Phenotype" University of Toronto Annual Neuromuscular Day; University of Toronto (2013)
  • "Update on the Thymectomy Trial in Nonthymomatous MG" 12th International Conference on MG and Related Disorders; New York Academy of Science (2012)
  • "Thymectomy trial in non-thymomatous MG patients receiving prednisone (MGTX)" Immune Globe International Conference of Nervous System Autoimmunity; Neuro Globe (2012)
  • "Thymectomy in Immune MG" UC Irvine MDA ALS and Neuromuscular Inaugural California Neuromuscular Sympsium; UC Irvine; Neurology (2011)
  • "Update for MG" Arizona Neurological Society CME Conference; Arizona Neurological Society (2009)
  • "UnMuSKing a New Phenotype and the Thymectomy Trial" Japanese Society of Neurology; Japanese Society of Neurology; 50th Annual Meeting (2009)
  • "Treatment update in MG and other disorders of the NMJ" Update in Neuromuscular Diseases, Oregon Health and Science University; Oregon Health and Science University (2009)
See all (92 more)

Service Activities:

  • NIH/NINDS Special Emphasis Panel in Clinical Trial Readiness for Rare Neurological and Neuromuscular Diseases and Functional Neurological Disorders; Primary reviewer (2023)
  • Food & Drug Administration, Cellular, Tissue, Gene Therapy Advisory Committee; Special Government Employee (2021–present)
  • Food & Drug Administration, Cellular, Tissue, Gene Therapy Advisory Committee, Special Government Employee; Member, Special Government Employee (2021–present)
  • Recruitment, Retention and Diversity Cmte, NeuroNEXT NINDS/NIH clinical trial network; Co-Chair (2021–present)
  • New York State Neurological Society; President (2018–2020)
  • New York State Neurological Society; Vice President (2017–2018)
  • Electromyography laboratory; Clinical Staff (2012–present)
  • Intraoperative monitoring Monitoring of surgical cases at Buffalo General Medical Center; Program Coordinator (2012–2020)
  • Neurophysiology laboratory EMG and intraoperative monitoring services; Clinical Staff (2012–present)
  • NINDS; NINDS Myasthenia Gravis Common Data Elements Group;; Chair (2012–present)
  • Neuromuscular Clinic Weekly clinic at BGMC; Clinical Staff (2012–present)
  • Executive; Member (2012–present)
  • FPMP Governing Board; Member (2012–present)
  • Inpatient General Neurology Service Four weeks a year attending on service with residents; Teacher (2012–present)
  • Medical Scientific Advisory Board; Chair (2011–present)
  • Neuropathy Measures Workgroup; Member (2011–2012)
  • NINDS; NINDS Neuromuscular Disease Common Data Elements Group;; Panel Member (2011–2012)
  • Practice Issues Review Panel; Member (2010–2014)
  • Myasthenia Gravis Foundation of America; Myasthenia Gravis Foundation of America;; Grant Reviewer (2009–present)
  • Neuromuscular Medicine Board Committee; Member (2009–present)
  • Neuromuscular Update Committee; Chair (2007–2010)
  • Myasthenia Gravis Foundation of America; Myasthenia Gravis Foundation of America;; Chair (2007–2008)
  • Department of Defense; Department of Defense;; Ad Hoc Reviewer (2003)

School News:

In the Media:


Clinical Specialties:

Clinical Offices:

Insurance Accepted:



Contact Information

Dept. of Neurology
Jacobs School of Medicine and Biomedical Sciences
1010 Main St., 2nd floor
Buffalo, New York 14202
Phone: (716) 829-5063
Fax: (716) 829-4411
gilwolfe@buffalo.edu

This faculty member is affiliated with UBMD, practicing physicians who are also professors in the Jacobs School.

View this physician on UBMD